Evidence map›Paper›PMID 37551166›Full record

ReviewAsian biomedicine : research, reviews and news2022

Sialic acid: an attractive biomarker with promising biomedical applications.

Aida Doostkam, Leila Malekmakan, Alireza Hosseinpour, Sahar Janfeshan, Jamshid Roozbeh, Fatemeh Masjedi

Abstract readReview
In one paragraph

Review in Asian biomedicine : research, reviews and news, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Functional characterization of a novel ZIP8 variant causing impaired manganese homeostasis and congenital disorders of glycosylation.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Protein N -Glycans in Healthy and Sclerotic Glomeruli in Diabetic Kidney Disease.Journal of the American Society of Nephrology : JASN · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aida DoostkamShiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz 7193635899, Iran.ORCID https://orcid.org/0000-0003-3348-573X
Leila MalekmakanShiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz 7193635899, Iran.ORCID https://orcid.org/0000-0002-3868-9523
Alireza HosseinpourStudent Research Committee, Shiraz University of Medical Sciences, Shiraz 7134853185, Iran.ORCID https://orcid.org/0000-0002-4175-8059
Sahar JanfeshanShiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz 7193635899, Iran.ORCID https://orcid.org/0000-0002-5400-2736
Jamshid RoozbehShiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz 7193635899, Iran.ORCID https://orcid.org/0000-0002-4268-1727
Fatemeh MasjediShiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz 7193635899, Iran.ORCID https://orcid.org/0000-0003-0534-7129

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This broad, narrative review highlights the roles of sialic acids as acidic sugars found on cellular membranes. The role of sialic acids in cellular communication and development has been well established. Recently, attention has turned to the fundamental role of sialic acids in many diseases, including viral infections, cardiovascular diseases, neurological disorders, diabetic nephropathy, and malignancies. Sialic acid may be a target for developing new drugs to treat various cancers and inflammatory processes. We recommend the routine measurement of serum sialic acid as a sensitive inflammatory marker in various diseases.

Indexed as

cardiovascular diseasesdiabetic nephropathiesmolecular targeted therapyneoplasmsneuraminic acidssialic acidvirus diseases

Identifiers

PMID37551166
PMCPMC10321195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.